Loncar Cancer Immunotherapy ETF (CNCR) — ETF Analysis on Winston
Key Facts
- Category: Equity
- Asset Class: Equity
- Price: $9.02
- Expense Ratio: 79.00%
- Assets Under Management: $13M
- Number of Holdings: 31
- Inception Date: 2015-10-14
- Currency: USD
Winston Score
Loncar Cancer Immunotherapy ETF has a Winston Score of 55 out of 100.
Sector Breakdown
Cash & Others (N/A%), Financial Services (N/A%), Healthcare (N/A%)